Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RAS-MAPK pathway is a highly conserved signal transduction cascade that relays extracellular signals from cell surface receptors to the nucleus, regulating key cellular processes such as proliferation, differentiation, survival, and gene expression. Dysregulation of this pathway is implicated in many cancers and other diseases, making it a major focus for cancer therapy development.
Varies depending on the specific drug and target within the pathway (e.g., inhibition of kinase activity).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAS-MAPK Pathway.